Previous research has shown the recombinant zoster vaccine is more effective than its live-attenuated predecessor, but new ...

Two doses of RZV were effective against HZ among adult patients aged 50 years and older with autoimmune diseases.

Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster vaccine was associated with a ...

New evidence bolsters the case that getting a shingles vaccine not only reduces the risk of herpes zoster infection but also ...

Adults vaccinated against shingles had an 18 per cent lower risk of serious heart problems, the analysis found. View on ...

Large-scale trials presented at the European Society of Cardiology Congress showed that vaccines against influenza and ...

The shingles vaccine not only protects against the painful skin infection, but also might provide heart health benefits, a new study says. Shingles vaccination also appears to lower a person’s risk of ...

New research shows the shingles vaccine can lower your risk of stroke and heart attack—in addition to preventing the total agony of a blistering rash.

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...

In clinical trials, Shingrix did not cause any serious side effects. In fact, serious side effects from vaccines are ...

This is the “number one most important vaccine” for everyone over six months or older, and “especially for people over 50,” ...